Comparison of 3 Phenotypic-detection Methods for Identifying Plasmid-mediated AmpC β-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Strains
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : Plasmid-mediated AmpC β-lactamases (PABLs) have been detected in the strains of Escherichia coli, Klebsiella spp., Proteus mirabilis, and Salmonella spp. PABLs may be difficult to detect and might interfere in the therapeutic and infection-control processes. Although several PABL-detection methods based on phenotypes have been reported, the Clinical and Laboratory Standards Institute currently does not recommend a routine detection method for PABLs. The aim of this study is to compare the performances of 3 phenotypic PABL detection methods. Methods : Total 276 non-duplicated clinical isolates of E. coli (N=97), K. pneumoniae (N=136), and P. mirabilis (N=43) were collected from 14 hospitals in Korea between April and June 2007 in a non-consecutive and non-random manner. Multiplex PCR was performed to detect the PABL genes. Further, 3 phenotypic detection methods-cephamycin-Hodge test, Tris-EDTA (TE) disk test, and combination-disk test with 3-aminophenylboronic acid (BA)-were performed using cefoxitin and cefotetan disks. Results : PABL genes were detected by multiplex PCR in 122/276 isolates, including 14/97 E. coli, 105/136 K. pneumoniae, and 3/43 P. mirabilis isolates. The combination-disk test with BA showed higher sensitivity (98.4%), specificity (92.2%), and efficiency (96.3%) than the cephamycin-Hodge (76.2%, 96.1%, and 88.6%, respectively) and the TE-disk (80.3%, 91.6%, and 87.9%, respectively) tests. Conclusions : The combination-disk test with BA is a simple, efficient, and interpretable test that can be applicable in clinical laboratories involved in the detection of PABLs in clinical isolates of E. coli, K. pneumoniae, and P. mirabilis.
Abstract
Background : Plasmid-mediated AmpC β-lactamases (PABLs) have been detected in the strains of Escherichia coli, Klebsiella spp., Proteus mirabilis, and Salmonella spp. PABLs may be difficult to detect and might interfere in the therapeutic and infection-control processes. Although several PABL-detection methods based on phenotypes have been reported, the Clinical and Laboratory Standards Institute currently does not recommend a routine detection method for PABLs. The aim of this study is to compare the performances of 3 phenotypic PABL detection methods. Methods : Total 276 non-duplicated clinical isolates of E. coli (N=97), K. pneumoniae (N=136), and P. mirabilis (N=43) were collected from 14 hospitals in Korea between April and June 2007 in a non-consecutive and non-random manner. Multiplex PCR was performed to detect the PABL genes. Further, 3 phenotypic detection methods-cephamycin-Hodge test, Tris-EDTA (TE) disk test, and combination-disk test with 3-aminophenylboronic acid (BA)-were performed using cefoxitin and cefotetan disks. Results : PABL genes were detected by multiplex PCR in 122/276 isolates, including 14/97 E. coli, 105/136 K. pneumoniae, and 3/43 P. mirabilis isolates. The combination-disk test with BA showed higher sensitivity (98.4%), specificity (92.2%), and efficiency (96.3%) than the cephamycin-Hodge (76.2%, 96.1%, and 88.6%, respectively) and the TE-disk (80.3%, 91.6%, and 87.9%, respectively) tests. Conclusions : The combination-disk test with BA is a simple, efficient, and interpretable test that can be applicable in clinical laboratories involved in the detection of PABLs in clinical isolates of E. coli, K. pneumoniae, and P. mirabilis.
참고문헌 (24)
- Yang K, "Diagnosis and treatment of extendedspectrum and AmpC β-lactamase-producing organisms", Ann Pharmacother, 41, pp.1427~1435 (2007)
- Papanicolaou GA, "Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae", Antimicrob Agents Chemother, 34, pp.2200~2209 (1990)
- Ardanuy C, "Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems", Antimicrob Agents Chemother, 42, pp.1636~1640 (1998)
- Coudron PE, "Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis", J Clin Microbiol, 43, pp.4163~4167 (2005)
- Black JA, "AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases", J Clin Microbiol, 43, pp.3110~3113 (2005)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement, M100-S17" (2007), Clinical and Laboratory Standards Institute
- Coudron PE, "Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center", J Clin Microbiol, 38, pp.1791~1796 (2000)
- Yong D, "Further modification of the Hodge test to screen AmpC β-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae", J Microbiol Methods, 52, pp.407~410 (2002)
- Netzel TC, "The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum β-lactamases in Escherichia coli", Diagn Microbiol Infect Dis, 58, pp.345~348 (2007)
- Beesley T, "The inhibition of class C β-lactamases by boronic acids", Biochem J, 209, pp.229~233 (1983)
- Yagi T, "Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli", J Clin Microbiol, 43, pp.2551~2558 (2005)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Approved Standard, M02-A9. Wayne, PA: Clinical and Laboratory Standards Institute", ~ (2006)
- Perez-Perez FJ, "Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR", J Clin Microbiol, 40, pp.2153~2162 (2002)
- Tan TY, "Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis", Antimicrob Agents Chemother, 53, pp.146~149 (2009)
- Song W, "Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis", Diagn Microbiol Infect Dis, 57, pp.315~318 (2007)
- Ayers LW, "Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, β-lactamase stability, and preliminary recommendations for disk diffusion testing", Antimicrob Agents Chemother, 22, pp.859~877 (1982)
- Wachino J, "Molecular characterization of a cephamycin-hydrolyzing and inhibitorresistant class A β-lactamase, GES-4, possessing a single G170S substitution in the omega-loop", Antimicrob Agents Chemother, 48, pp.2905~2910 (2004)
- Poirel L, "Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France", Antimicrob Agents Chemother, 44, pp.891~897 (2000)
- Martinez-Martinez L, "Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae", Antimicrob Agents Chemother, 43, pp.1669~1673 (1999)
- Martinez-Martinez L, "In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins", Antimicrob Agents Chemother, 40, pp.342~348 (1996)
- Hernandez-Alles S, "Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae", J Antimicrob Chemother, 46, pp.273~277 (2000)
- Hernandez-Alles S, "Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes", Antimicrob Agents Chemother, 43, pp.937~939 (1999)
- Jacoby GA, "AmpC β-lactamases", Clin Microbiol Rev, 22, pp.161~182 (2009)
- Doi Y, "Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type β-lactamase by use of a boronic acid compound", J Clin Microbiol, 46, pp.4083~4086 (2008)